Epigenome Editing Therapy Raises Hopes for a Functional Cure for Chronic Hepatitis B

CRISPR’s next act: the companies editing the epigenome to treat disease

CRISPR’s next act: companies editing the epigenome to treat disease “Changing the epigenetic tags on a genome is akin to using an audio mixi

CRISPR’s next act: the companies editing the epigenome to treat disease

A feature in Nature reports how a handful of start-up firms are testing therapies that target specific epigenetic markers to treat everythin

Phase 3 Trials Show Bepirovirsen Achieves Functional Cure for Hepatitis B in 20% of Patients

Bepirovirsen reduced posttreatment markers of hepatitis B infection at 72 weeks, with 20% of recipients achieving functional cure vs none gi

CRISPR’s next act: the companies editing the epigenome to treat disease

#Medsky🧪 #Publichealth Most epigenetic-editing platforms, rather than making changes to the DNA itself, modify the markers attached to DNA.

ToxiTaRGET: a multi-omics database for toxicant-responsive molecular targets

Check out ToxiTaRGET, a multi-omics database detailing 1000+ toxicant-induced changes in transcriptome & epigenome. Vital for disease risk a

<![CDATA[Functional Cure of Hepatitis B Infections Among Patients Coinfected With HIV]]>